Document Detail


Anticancer medicines (Doxorubicin and methotrexate) conjugated with magnetic nanoparticles for targeting drug delivery through iron.
MedLine Citation:
PMID:  23876138     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
The uptake of iron is increased by cancer cells. Iron magnetic nanoparticles (MNP) can be used as a nanovehicle for immobilization of anticancer medicines and to integrate them at a target site. The anticancer medicines doxorubicin (DOX) and methotrexate (MTX) were immobilized separately and in combination onto MNP by a glutaraldehyde activation method and confirmed by magnetic nanoparticles linked immunosorbent assay (MagLISA) and Fourier-transform infrared (FTIR) spectroscopy. The phenol peaks of DOX and MTX at 2896.6 cm(-1) to 2912.5 cm(-1) in FTIR spectra of immobilized medicines indicated the conjugation. Affinity-purified anti-DOX and anti-MTX antibodies were used to evaluate the coupling of DOX and MTX onto MNP, and the binding was found 34.6% to 37.2% and 51.8% to 54.3% separately, respectively. The immobilization of DOX and MTX in combination onto MNP was 18% and 27%, respectively. HeLa and B cells were cultured with DOX-MNP, MTX-MNP, and DOX-MNP-MTX separately, and MagLISA indicated that the binding of DOX-MNP/MTX-MNP was 41.5% to 45% with HeLa cells and 20% to 26% with B cells. No significant difference was observed in binding of DOX-MNP-MTX with HeLa and B cells. Results also indicated that the release of medicines at pH 5.0 is more (39% to 44%) than at pH 7.4 (3.7% to 10.2%). Sixteen to 22% more killing effect was observed on HeLa cells than on B cells. In immunohistochemical staining, more deposition of brown color on HeLa cells than on B cells may be due to more expression of iron-binding sites on cancer cells. The dual property of MNP can be used for binding of medicines and for targeting drug delivery.
Authors:
Zahoor Qadir Samra; Snober Ahmad; Mehwish Javeid; Nadia Dar; Muhammad Shahbaz Aslam; Iram Gull; Mubashar Mustaneer Ahmad
Related Documents :
24110988 - Distinct patterns of cell motion inside a micro-channel under different osmotic conditi...
22438018 - Cell proliferation and apoptosis in gill filaments of the lucinid codakia orbiculata (m...
23042508 - Hydrodynamic resettability for a microfluidic particulate-based arraying system.
24375438 - Expression of chromobox homolog 7 (cbx7) is associated with poor prognosis in ovarian c...
8054538 - Biosynthesis and processing of the glycosylphosphatidylinositol anchor in mammalian cells.
19537828 - Capture of drug targets from live cells using a multipurpose immuno-chemo-proteomics tool.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Preparative biochemistry & biotechnology     Volume:  43     ISSN:  1532-2297     ISO Abbreviation:  Prep. Biochem. Biotechnol.     Publication Date:  2013 Nov 
Date Detail:
Created Date:  2013-07-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9607037     Medline TA:  Prep Biochem Biotechnol     Country:  England    
Other Details:
Languages:  eng     Pagination:  781-97     Citation Subset:  IM    
Affiliation:
a Institute of Biochemistry and Biotechnology, Quaid-i-Azam Campus , University of the Punjab , Lahore , Pakistan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  STATISTICAL APPROACH FOR THE ENHANCED PRODUCTION OF COLD-ACTIVE ?-GALACTOSIDASE FROM Thalassospira f...
Next Document:  Enzymatic surface hydrolysis of polyamide 6,6 with mixtures of proteolytic and lipolytic enzymes.